Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2918 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- TRP-1 Antibody Cocktail
- Antibody type
- Monoclonal
- Antigen
- SK-MEL-23 cells (TA99) and recombinant full-length human protein (TYRP1/807) were used as the immunogen for the TRP-1 antibody cocktail.
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- TA99 + TYRP1/807
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the TRP-1 antibody cocktail at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references A switchable yeast display/secretion system.
Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution.
SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.
Targeted delivery of a sialic acid-blocking glycomimetic to cancer cells inhibits metastatic spread.
Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.
Van Deventer JA, Kelly RL, Rajan S, Wittrup KD, Sidhu SS
Protein engineering, design & selection : PEDS 2015 Oct;28(10):317-25
Protein engineering, design & selection : PEDS 2015 Oct;28(10):317-25
Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution.
Tzeng A, Kwan BH, Opel CF, Navaratna T, Wittrup KD
Proceedings of the National Academy of Sciences of the United States of America 2015 Mar 17;112(11):3320-5
Proceedings of the National Academy of Sciences of the United States of America 2015 Mar 17;112(11):3320-5
SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.
El Hajj P, Gilot D, Migault M, Theunis A, van Kempen LC, Salés F, Fayyad-Kazan H, Badran B, Larsimont D, Awada A, Bachelot L, Galibert MD, Ghanem G, Journe F
British journal of cancer 2015 Jun 30;113(1):91-8
British journal of cancer 2015 Jun 30;113(1):91-8
Targeted delivery of a sialic acid-blocking glycomimetic to cancer cells inhibits metastatic spread.
Büll C, Boltje TJ, van Dinther EA, Peters T, de Graaf AM, Leusen JH, Kreutz M, Figdor CG, den Brok MH, Adema GJ
ACS nano 2015 Jan 27;9(1):733-45
ACS nano 2015 Jan 27;9(1):733-45
Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.
Mosenson JA, Flood K, Klarquist J, Eby JM, Koshoffer A, Boissy RE, Overbeck A, Tung RC, Le Poole IC
Pigment cell & melanoma research 2014 Mar;27(2):209-20
Pigment cell & melanoma research 2014 Mar;27(2):209-20
No comments: Submit comment
No validations: Submit validation data